Works matching DE "TELAPREVIR"
Results: 203
Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?
- Published in:
- Nephrology, 2015, v. 20, n. 11, p. 843, doi. 10.1111/nep.12517
- By:
- Publication type:
- Article
Recent Advances on Hepatitis C Virus in Dialysis Population.
- Published in:
- Kidney & Blood Pressure Research, 2014, v. 39, n. 4, p. 260, doi. 10.1159/000355803
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 10, p. 919, doi. 10.1007/s40273-013-0080-3
- By:
- Publication type:
- Article
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.
- Published in:
- International Journal of Hepatology, 2014, p. 1, doi. 10.1155/2014/723868
- By:
- Publication type:
- Article
Interpreting discordant indirect and multipletreatment comparison meta-analyses:an evaluation of direct acting antiviralsfor chronic hepatitis C infection.
- Published in:
- Clinical Epidemiology, 2013, v. 5, p. 173, doi. 10.2147/CLEP.S44273
- By:
- Publication type:
- Article
Telaprevir Warning.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 309, n. 4, p. 333, doi. 10.1001/jama.2013.22
- Publication type:
- Article
Antiviral Medications, Part 4: Evidence-Based Treatment of Hepatitis C.
- Published in:
- MEDSURG Nursing, 2018, v. 27, n. 1, p. 49
- By:
- Publication type:
- Article
Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir.
- Published in:
- Virology Journal, 2014, v. 11, n. 1, p. 1, doi. 10.1186/1743-422X-11-93
- By:
- Publication type:
- Article
Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatment.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 12, n. 5, p. 3353, doi. 10.3892/etm.2016.3785
- By:
- Publication type:
- Article
Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 11, n. 5, p. 1781, doi. 10.3892/etm.2016.3133
- By:
- Publication type:
- Article
Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve.
- Published in:
- Experimental & Therapeutic Medicine, 2015, v. 10, n. 4, p. 1334, doi. 10.3892/etm.2015.2674
- By:
- Publication type:
- Article
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake.
- Published in:
- HIV Medicine, 2015, v. 16, n. 10, p. 599, doi. 10.1111/hiv.12269
- By:
- Publication type:
- Article
Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection.
- Published in:
- HIV Medicine, 2014, v. 15, n. 2, p. 108, doi. 10.1111/hiv.12086
- By:
- Publication type:
- Article
HIV and HCV Medications in End-Stage Renal Disease.
- Published in:
- Seminars in Dialysis, 2015, v. 28, n. 4, p. 397, doi. 10.1111/sdi.12367
- By:
- Publication type:
- Article
Spending on Hepatitis C Antivirals in the United States, 2009-2015.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 1, p. 65, doi. 10.1002/phar.1865
- By:
- Publication type:
- Article
Darunavir and telaprevir drug interaction: total and unbound plasma concentrations in HIV/HCV-coinfected patients with cirrhosis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 5, p. 1434, doi. 10.1093/jac/dkt509
- By:
- Publication type:
- Article
Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 2, p. 483, doi. 10.1093/jac/dkt371
- By:
- Publication type:
- Article
Potential P-glycoprotein Pharmacokinetic Interaction of Telaprevir With Morphine or Methadone.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2013, v. 27, n. 3, p. 261, doi. 10.3109/15360288.2013.803512
- By:
- Publication type:
- Article
Care management programs key to helping deal with complexities of hepatitis C medication adherence.
- Published in:
- Formulary, 2013, v. 48, n. 5, p. 1
- Publication type:
- Article
Telaprevir: A novel, protease inhibitor for the treatment of hepatitis C virus.
- Published in:
- Formulary, 2011, v. 46, n. 6, p. 205
- By:
- Publication type:
- Article
Shorter treatment for HCV may be possible with protease inhibitor.
- Published in:
- Formulary, 2011, v. 46, n. 5, p. 158
- Publication type:
- Article
High Frequency of Severe Telaprevir-associated Skin Eruptions in Clinical Practice.
- Published in:
- Acta Dermato-Venereologica, 2016, v. 96, n. 1, p. 97, doi. 10.2340/00015555-2174
- By:
- Publication type:
- Article
Comment to “Telaprevir Experience From Turkey”.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy.
- Published in:
- Hepatitis Monthly, 2015, v. 15, n. 9, p. 1, doi. 10.5812/hepatmon.28879
- By:
- Publication type:
- Article
Hepatitis C Treatment: Improved Efficacy and Tolerability.
- Published in:
- South Dakota Medicine, 2014, v. 67, n. 10, p. 419
- By:
- Publication type:
- Article
Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients?
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 4, p. e194, doi. 10.1111/jdv.13936
- By:
- Publication type:
- Article
Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. 3, p. 366, doi. 10.5604/01.3001.0009.8591
- By:
- Publication type:
- Article
High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2015, v. 14, n. 4, p. 477, doi. 10.1016/s1665-2681(19)31169-x
- By:
- Publication type:
- Article
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
First confirmed case of native polyomavirus BK nephropathy in a liver transplant recipient seven years post-transplanterferon a, ribavirin and telaprevir.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2015, v. 14, n. 1, p. 137, doi. 10.1016/s1665-2681(19)30812-9
- By:
- Publication type:
- Article
Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2015, v. 14, n. 1, p. 132, doi. 10.1016/s1665-2681(19)30811-7
- By:
- Publication type:
- Article
Boceprevir and telaprevir for chronic genotype 1 hepatitis C virus infection. A systematic review and meta-analysis.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2015, v. 14, n. 1, p. 46, doi. 10.1016/s1665-2681(19)30800-2
- By:
- Publication type:
- Article
Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2015, v. 14, n. 1, p. 28, doi. 10.1016/s1665-2681(19)30798-7
- By:
- Publication type:
- Article
Chronic hepatitis C successfully treated with telaprevir, pegylated interferon and ribavirin in severe aplastic anemia.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
A strategy for early-risk predictions of clinical drug–drug interactions involving the GastroPlus DDI module for time-dependent CYP inhibitors.
- Published in:
- Xenobiotica, 2018, v. 48, n. 4, p. 348, doi. 10.1080/00498254.2017.1323136
- By:
- Publication type:
- Article
Intrahepatic and Peripheral CXCL10 Expression in Hepatitis C Virus-Infected Patients Treated With Telaprevir, Pegylated Interferon, and Ribavirin.
- Published in:
- Journal of Infectious Diseases, 2015, v. 211, n. 11, p. 1795, doi. 10.1093/infdis/jiu807
- By:
- Publication type:
- Article
Deep-Sequencing Analysis of the Gene Encoding the Hepatitis C Virus Nonstructural 3–4A Protease Confirms a Low Prevalence of Telaprevir-Resistant Variants at Baseline and the End of the REALIZE Study.
- Published in:
- Journal of Infectious Diseases, 2014, v. 210, n. 12, p. 1871, doi. 10.1093/infdis/jiu340
- By:
- Publication type:
- Article
Telaprevir Activity in Treatment-Naive Patients Infected With Hepatitis C Virus Genotype 4.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 6, p. 1000, doi. 10.1093/infdis/jit274
- By:
- Publication type:
- Article
Outcomes of treatment with direct-acting antivirals for infection with hepatitis C virus genotypes 1-4 in an ambulatory care setting.
- Published in:
- American Journal of Health-System Pharmacy, 2017, v. 74, p. S1, doi. 10.2146/ajhp160567
- By:
- Publication type:
- Article
Apparent interaction between telaprevir and warfarin in a patient with chronic hepatitis C viral infection.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
A Translational Study of Resistance Emergence Using Sequential Direct-Acting Antiviral Agents for Hepatitis C Using Ultra-Deep Sequencing.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 9, p. 1464, doi. 10.1038/ajg.2013.205
- By:
- Publication type:
- Article
HCV RNA Viral Load Assessments in the Era of Direct-Acting Antivirals.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 4, p. 471, doi. 10.1038/ajg.2012.248
- By:
- Publication type:
- Article
Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment.
- Published in:
- AIDS Research & Therapy, 2017, v. 14, p. 1, doi. 10.1186/s12981-017-0182-7
- By:
- Publication type:
- Article
Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma.
- Published in:
- Oncology, 2015, v. 89, p. 42, doi. 10.1159/000440630
- By:
- Publication type:
- Article
Efficacy and Safety of Telaprevir-Based Antiviral Treatment for Elderly Patients with Hepatitis C Virus.
- Published in:
- Oncology, 2014, v. 87, p. 110, doi. 10.1159/000368154
- By:
- Publication type:
- Article
Telaprevir-Induced DRESS Syndrome Associated With Salmonella typhi.
- Published in:
- ACG Case Reports Journal, 2015, v. 2, n. 2, p. 79, doi. 10.14309/crj.2015.10
- By:
- Publication type:
- Article
Prevalence and Predictors of Important Telaprevir Drug Interactions Among Patients Coinfected With Hepatitis C and Human Immunodeficiency Virus.
- Published in:
- Journal of Pharmacy Technology, 2014, v. 30, n. 5, p. 159, doi. 10.1177/8755122514533941
- By:
- Publication type:
- Article
New Triple Therapy for Chronic Hepatitis C: Real Life Clinical Experience in a Community Setting.
- Published in:
- Hawaii Journal of Medicine & Public Health, 2013, v. 72, n. 9, p. 6
- By:
- Publication type:
- Article